{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:52:25Z","timestamp":1792173145729,"version":"4.4.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"High-level TCM Key Discipline Construction Project of the National Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023237"],"award-info":[{"award-number":["zyyzdxk-2023237"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction is central to type 2 diabetes mellitus (T2DM) pathogenesis, driving insulin resistance and pancreatic \u03b2-cell dysfunction. Age-related mitochondrial impairment worsens this in older adults, yet evidence on mitochondrial interventions for this group is limited. This protocol outlines a systematic review and conditional network meta-analysis of randomized controlled trials evaluating mitochondrial interventions in adults aged 60+ with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary objective of this systematic review and conditional network meta-analysis (NMA) is to evaluate the comparative efficacy and safety of diverse mitochondrial-related interventions, including pharmacological agents, nutritional supplements, and lifestyle modifications, relative to placebo, standard care, or no intervention, on mitochondrial function biomarkers in adults aged 60 years or older with type 2 diabetes mellitus (T2DM). Interventions with mitochondrial effects are operationally defined as those whose primary mechanism is known to target mitochondrial pathways or those that are explicitly evaluated for their effects on direct markers of mitochondrial function in the trial.<\/jats:p>\n                    <jats:p>The secondary objectives are: (1) to assess the impact of these interventions on glycemic and metabolic control outcomes including glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), body weight, and body mass index (BMI); (2) to conduct a conditional NMA to compare and rank the relative efficacy of different intervention categories if the evidence network is sufficiently connected and clinically coherent; and (3) to explore potential sources of heterogeneity (e.g., intervention duration, baseline HbA1c levels) via prespecified subgroup and sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Prepared per PRISMA-P, the review will follow PRISMA 2020 and PRISMA-NMA if applicable. Registered with PROSPERO (ID: CRD420251145356), searches will cover PubMed, Embase, Cochrane CENTRAL, Web of Science, and Scopus from inception to April 2026. Focused on T2DM, mitochondrial function\/dysfunction, and interventions, age eligibility will be assessed during full-text screening. Primary analysis includes trials with participants aged 60+ or extractable data for this group; sensitivity analyses will include those with mean\/median age\u2009\u2265\u200960. Two reviewers will handle screening, data extraction, and bias assessment using RoB 2.Analysis will focus on trials reporting mitochondrial function outcomes, categorized by biological domain, tissue source, and assay method. Glycemic control, geriatric health, and safety are secondary outcomes. Network meta-analysis will be conducted if a connected evidence network exists; otherwise, pairwise meta-analysis or narrative synthesis will be used. Random-effects models will be employed, with heterogeneity assessed via subgroup analysis and meta-regression. If significant heterogeneity persists, a Synthesis Without Meta-Analysis (SWiM) framework narrative review will be done. Evidence certainty will be appraised using GRADE and CINeMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      Ethics approval is not required for this systematic review as the systematic review will include only previously anonymised data from primary studies. Dissemination of the findings of the final systematic review will occur through publishing in a peer-reviewed journal.\n                      <jats:bold>PROSPERO registration number<\/jats:bold>\n                      CRD420251145356\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0360683","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:25:31Z","timestamp":1792171531000},"page":"e0360683","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventions with mitochondrial-related effects in older adults with type 2 diabetes: Protocol for a systematic review with conditional network meta-analysis"],"prefix":"10.1371","volume":"21","author":[{"given":"Hao","family":"Liu","sequence":"first","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aochuan","family":"Sun","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]},{"name":"Macau University of Science and Technology","place":["Macau, China"],"department":["Faculty of Chinese Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Li","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Hu","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-7711","authenticated-orcid":true,"given":"Zhengtang","family":"Liu","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"],"department":["Xiyuan Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"9","key":"pone.0360683.ref001","first-page":"1570","article-title":"Analysis and prediction of prevalence, disease burden of type 2 diabetes mellitus and risk factors in China from 1990 to 2021 in a global context","volume":"46","author":"AB Qu","year":"2025","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"pone.0360683.ref002","article-title":"Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: Insights from 1990 to 2021","volume":"16","author":"X Yu","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"10","key":"pone.0360683.ref003","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.tem.2024.12.006","article-title":"The growing range of complications of diabetes mellitus","volume":"36","author":"PS Hamblin","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"pone.0360683.ref004","doi-asserted-by":"crossref","first-page":"1693166","DOI":"10.3389\/fendo.2025.1693166","article-title":"Co-occurrence patterns and related risk factors of ischemic heart disease and type 2 diabetes in burden of disability-adjusted life years among people aged 55 years and older across 203 countries and territories","volume":"16","author":"Y Luo","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"pone.0360683.ref005","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00125-019-4934-x","article-title":"Cellular senescence: At the nexus between ageing and diabetes","volume":"62","author":"AK Palmer","year":"2019","journal-title":"Diabetologia"},{"issue":"8","key":"pone.0360683.ref006","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1111\/dom.16471","article-title":"Burden of type 2 diabetes mellitus and risk factor attribution among older adults: A global, regional, and national analysis from 1990 to 2021, with projections up to 2040","volume":"27","author":"L Lin","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"pone.0360683.ref007","doi-asserted-by":"crossref","first-page":"1429048","DOI":"10.3389\/fendo.2025.1429048","article-title":"The global incidence rate of type 2 diabetes related chronic kidney disease and predictions by Bayesian age-period-cohort analysis: Findings from the Global Burden of Disease Study 2019","volume":"16","author":"J Yu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"pone.0360683.ref008","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"E M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"pone.0360683.ref009","doi-asserted-by":"crossref","first-page":"1354199","DOI":"10.3389\/fmolb.2024.1354199","article-title":"Mitochondrial bioenergetics, metabolism, and beyond in pancreatic \u03b2-cells and diabetes","volume":"11","author":"AM Rivera Nieves","year":"2024","journal-title":"Front Mol Biosci"},{"issue":"1","key":"pone.0360683.ref010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances","volume":"10","author":"X Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"pone.0360683.ref011","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.redox.2014.07.005","article-title":"Mitochondrial stress signaling in longevity: A new role for mitochondrial function in aging","volume":"2","author":"S Hill","year":"2014","journal-title":"Redox Biol"},{"key":"pone.0360683.ref012","doi-asserted-by":"crossref","first-page":"100940","DOI":"10.1016\/j.arr.2019.100940","article-title":"Mitochondria in the signaling pathways that control longevity and health span","volume":"54","author":"M Akbari","year":"2019","journal-title":"Ageing Res Rev"},{"issue":"23","key":"pone.0360683.ref013","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/cells14231861","article-title":"\u03b2-Cell mitochondrial dysfunction: Underlying mechanisms and potential therapeutic strategies","volume":"14","author":"R Darwish","year":"2025","journal-title":"Cells"},{"issue":"3","key":"pone.0360683.ref014","first-page":"1399","article-title":"Type 2 diabetes mellitus: A metabolic model of accelerated aging - multi-organ mechanisms and intervention approaches","volume":"17","author":"Z Zhang","year":"2025","journal-title":"Aging Dis"},{"issue":"9","key":"pone.0360683.ref015","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.3390\/ijms23094820","article-title":"The mighty mitochondria are unifying organelles and metabolic hubs in multiple organs of obesity, insulin resistance, metabolic syndrome, and type 2 diabetes: An observational ultrastructure study","volume":"23","author":"MR Hayden","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0360683.ref016","doi-asserted-by":"crossref","first-page":"112724","DOI":"10.1016\/j.exger.2025.112724","article-title":"Obesity classified by anthropometric parameters was associated with mitochondrial bioenergetics impairment of peripheral blood mononuclear cells in the elderly population","volume":"202","author":"T Attachaipanich","year":"2025","journal-title":"Exp Gerontol"},{"issue":"4","key":"pone.0360683.ref017","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijms25042052","article-title":"Mitochondrial quantity and quality in age-related sarcopenia","volume":"25","author":"E Marzetti","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"13","key":"pone.0360683.ref018","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3748\/wjg.v29.i13.1982","article-title":"Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver","volume":"29","author":"D Wang","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"3","key":"pone.0360683.ref019","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3390\/ijms24032967","article-title":"Crosstalk between adipose tissue and hepatic mitochondria in the development of the inflammation and liver injury during ageing in high-fat diet fed rats","volume":"24","author":"G Cavaliere","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0360683.ref020","doi-asserted-by":"crossref","first-page":"1627173","DOI":"10.3389\/fimmu.2025.1627173","article-title":"Integrative transcriptomic and machine learning analyses identify HDAC9 as a key regulator of mitochondrial dysfunction and senescence-associated inflammation in diabetic nephropathy","volume":"16","author":"J Huang","year":"2025","journal-title":"Front Immunol"},{"key":"pone.0360683.ref021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"NJ Byrne","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"pone.0360683.ref022","doi-asserted-by":"crossref","first-page":"1671926","DOI":"10.3389\/fphys.2025.1671926","article-title":"Effects of exercise training on skeletal muscle mitochondrial outcomes in type 2 diabetes: A systematic review and meta-analysis","volume":"16","author":"W Zhu","year":"2025","journal-title":"Front Physiol"},{"issue":"1","key":"pone.0360683.ref023","article-title":"The effects of glucagon-like peptide-1 receptor agonists on mitochondrial function within skeletal muscle: A systematic review","volume":"16","author":"VJ Old","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"22","key":"pone.0360683.ref024","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1080\/10408398.2026.2624477","article-title":"The effects of coenzyme Q10 supplementation on glycemic control in diabetic and non-diabetic individuals: A systematic review and meta-analysis","volume":"66","author":"N Collares L das","year":"2026","journal-title":"Crit Rev Food Sci Nutr"},{"key":"pone.0360683.ref025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2018.03.041","article-title":"Meta-analysis of mitochondrial T16189C polymorphism for cancer and Type 2 diabetes risk","volume":"482","author":"T Kumari","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"4","key":"pone.0360683.ref026","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.507","article-title":"Comparative determination of mitochondrial biomarkers and their relationship with insulin resistance in type 2 diabetic patients: An observational cross-sectional study","volume":"7","author":"EK Ofori","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"pone.0360683.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"key":"pone.0360683.ref028","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"pone.0360683.ref029","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations","volume":"162","author":"B Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7650","key":"pone.0360683.ref030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"key":"pone.0360683.ref031","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"MA Puhan","year":"2014","journal-title":"BMJ"},{"key":"pone.0360683.ref032","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"pone.0360683.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"A Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"pone.0360683.ref034","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"M Campbell","year":"2020","journal-title":"BMJ"},{"key":"pone.0360683.ref035","article-title":"13. Older Adults: Standards of Care in Diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","journal-title":"Diabetes Care"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:25:36Z","timestamp":1792171536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360683"}},"subtitle":[],"editor":[{"given":"Victor Manuel","family":"Mendoza-Nu\u00f1ez","sequence":"first","affiliation":[{"name":"UNAM Facultad de Estudios Superiores Zaragoza: Universidad Nacional Autonoma de Mexico Facultad de Estudios Superiores Zaragoza","place":["MEXICO"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0360683","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}